Global Direct-to-Consumer Genetic Testing Market 2022-2028
The global direct-to-consumer genetic testing market was valued at USD 1,405 million in 2021 to USD 3,559 million by 2028, progressing at a CAGR of 14.2% from 2022 to 2028, according to Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global direct-to-consumer genetic testing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the direct-to-consumer genetic testing industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, application, delivery format, and region. The global market for direct-to-consumer genetic testing can be segmented by technology: genotyping arrays, polymerase chain reaction (PCR), sequencing. Globally, the genotyping arrays segment made up the largest share of the direct-to-consumer genetic testing market. Direct-to-consumer genetic testing market is further segmented by application: ancestry, health and wellness. The ancestry segment captured the largest share of the market in 2021. Based on delivery format, the direct-to-consumer genetic testing market is segmented into: test kits, virtual tests. According to the research, the test kits segment had the largest share in the global direct-to-consumer genetic testing market. On the basis of region, the direct-to-consumer genetic testing market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America held the largest revenue share in 2021.
By technology:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook